ACADIA Pharmaceuticals
ACAD
#3644
Rank
โ‚ฌ2.33 B
Marketcap
14,03ย โ‚ฌ
Share price
-4.59%
Change (1 day)
-15.77%
Change (1 year)

Revenue for ACADIA Pharmaceuticals (ACAD)

Revenue in 2024 (TTM): โ‚ฌ0.88 Billion

According to ACADIA Pharmaceuticals's latest financial reports the company's current revenue (TTM ) is โ‚ฌ0.87 Billion. an increase over the revenue in the year 2023 that were of โ‚ฌ0.65 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for ACADIA Pharmaceuticals from 2003 to 2024

Annual revenue

Year Revenue Change
2024 โ‚ฌ0.92 B40.06%
2023 โ‚ฌ0.65 B36.28%
2022 โ‚ฌ0.48 B12.79%
2021 โ‚ฌ0.42 B19.03%
2020 โ‚ฌ0.35 B18.66%
2019 โ‚ฌ0.30 B54.72%
2018 โ‚ฌ0.19 B87.94%
2017 โ‚ฌ0.10 B531.78%
2016 โ‚ฌ16.47 M29433.7%
2015 โ‚ฌ0.05 M-43.92%
2014 โ‚ฌ0.09 M-88%
2013 โ‚ฌ0.82 M-77.65%
2012 โ‚ฌ3.7 M133.07%
2011 โ‚ฌ1.59 M-94.98%
2010 โ‚ฌ31.67 M609.36%
2009 โ‚ฌ4.46 M292.64%
2008 โ‚ฌ1.13 M-78.02%
2007 โ‚ฌ5.17 M-16.06%
2006 โ‚ฌ6.16 M-33.35%
2005 โ‚ฌ9.24 M172.49%
2004 โ‚ฌ3.39 M-45.35%
2003 โ‚ฌ6.21 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
โ‚ฌ0.18 B-79.25%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ58.03 B 6,542.95%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ41.08 B 4,602.74%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ81.02 B 9,173.47%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ44.05 B 4,942.82%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ80.44 M-90.79%๐Ÿ‡บ๐Ÿ‡ธ USA